本页面由Tiger Trade Technology Pte. Ltd.提供服务

PMV Pharmaceuticals

1.32
-0.0150-1.13%
成交量:14.71万
成交额:19.75万
市值:6,997.31万
市盈率:-0.93
高:1.36
开:1.33
低:1.31
收:1.33
52周最高:1.88
52周最低:1.02
股本:5,321.15万
流通股本:4,632.87万
量比:0.73
换手率:0.32%
股息:- -
股息率:- -
每股收益(TTM):-1.4131
每股收益(LYR):-1.4800
净资产收益率:-70.93%
总资产收益率:-42.39%
市净率:0.98
市盈率(LYR):-0.89

数据加载中...

2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/06

重要事件披露

Form 8-K - Current report
2025/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/12

重要事件披露

Form 8-K - Current report
2025/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/06/09

重要事件披露

Form 8-K - Current report